Device companies say FDA is venturing beyond its legal authority in a recent proposal to release data derived from marketing applications to researchers.
FDA issued its proposal in a Federal Register notice in June, which called for public comments on the concept of making masked and/or de-identified pre-clinical and clinical data from marketing applications available to third parties for independent research. The goal, FDA says, would be to allow outside experts to access data with research value in a way that would protect patient privacy and the commercial investments of product sponsors
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?